Staff
Checkmate Pharmaceuticals Presents New Clinical Trial Translational Data With Vidutolimod At The 2021 American Association For Cancer (AACR) Annual Meeting
Checkmate Pharmaceuticals Presents New Clinical Trial Translational Data With Vidutolimod At The 2021 American Association For Cancer (AACR) Annual Meeting CAMBRIDGE, Mass., April 11, 2021 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced the presentation of
BeiGene Presents Clinical Data On Sitravatinib In Combination With Tislelizumab At The AACR Annual Meeting 2021
BeiGene Presents Clinical Data On Sitravatinib In Combination With Tislelizumab At The AACR Annual Meeting 2021 BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that clinical data on its anti-PD-1 antibody tislelizumab, in combination with the investigational spectrum-selective kinase inhibitor sitravatinib being jointly developed with Mirati Therapeutics, Inc.
Lyra Therapeutics Presents Positive Full Data Set From LANTERN Phase 2 Study Of LYR-210 At COSM 2021 Virtual
Lyra Therapeutics Presents Positive Full Data Set From LANTERN Phase 2 Study Of LYR-210 At COSM 2021 Virtual Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat (ENT) diseases, today presented data from its Phase 2